This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 Jan;9(1):191-2.

doi: 10.1200/JCO.1991.9.1.191.

Median follow-up in clinical trials

PMID: 1985169
DOI: 10.1200/JCO.1991.9.1.191

Median follow-up in clinical trials

J J Shuster. J Clin Oncol. 1991 Jan.

. 1991 Jan;9(1):191-2.

doi: 10.1200/JCO.1991.9.1.191.

Author

PMID: 1985169
DOI: 10.1200/JCO.1991.9.1.191

No abstract available

PubMed Disclaimer

Similar articles

[Methodology of clinical trials].
Quantin X, Jacot W, Choma D, Pujol JL. Quantin X, et al. Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S13-6. Rev Pneumol Clin. 2001. PMID: 11924235 French. No abstract available.
Combining symptom and survival data.
Atherton PJ, Mandrekar SJ. Atherton PJ, et al. Curr Probl Cancer. 2006 Nov-Dec;30(6):307-18. doi: 10.1016/j.currproblcancer.2006.08.008. Curr Probl Cancer. 2006. PMID: 17123882 No abstract available.
Analysis of survival in cancer clinical trials.
Shimm D, Logue G. Shimm D, et al. Ann Intern Med. 1983 May;98(5 Pt 1):665-6. doi: 10.7326/0003-4819-98-5-665. Ann Intern Med. 1983. PMID: 6846980 No abstract available.
Statistical considerations for the next generation of clinical trials.
Wu W, Shi Q, Sargent DJ. Wu W, et al. Semin Oncol. 2011 Aug;38(4):598-604. doi: 10.1053/j.seminoncol.2011.05.014. Semin Oncol. 2011. PMID: 21810519 Review.
Endpoints in cancer clinical trials.
Fiteni F, Westeel V, Pivot X, Borg C, Vernerey D, Bonnetain F. Fiteni F, et al. J Visc Surg. 2014 Feb;151(1):17-22. doi: 10.1016/j.jviscsurg.2013.10.001. Epub 2014 Jan 14. J Visc Surg. 2014. PMID: 24440056 Review.

See all similar articles

Cited by

Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors.
Perelman MG, Brzezinski RY, Waissengrin B, Leshem Y, Bainhoren O, Rubinstein TA, Perelman M, Rozenbaum Z, Havakuk O, Topilsky Y, Banai S, Wolf I, Laufer-Perl M. Perelman MG, et al. Cardiooncology. 2024 Jan 11;10(1):2. doi: 10.1186/s40959-023-00199-6. Cardiooncology. 2024. PMID: 38212825 Free PMC article.
Area-Based Socioeconomic Inequalities in Colorectal Cancer Survival in Germany: Investigation Based on Population-Based Clinical Cancer Registration.
Jansen L, Behrens G, Finke I, Maier W, Gerken M, Pritzkuleit R, Holleczek B, Brenner H; German Cancer Survival Working Group. Jansen L, et al. Front Oncol. 2020 May 29;10:857. doi: 10.3389/fonc.2020.00857. eCollection 2020. Front Oncol. 2020. PMID: 32670870 Free PMC article.
Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.
Heeg E, Marang-van de Mheen PJ, Van Maaren MC, Schreuder K, Tollenaar RAEM, Siesling S, Bos MEMM, Vrancken Peeters MTFD. Heeg E, et al. Int J Cancer. 2020 Jul 1;147(1):152-159. doi: 10.1002/ijc.32788. Epub 2019 Nov 28. Int J Cancer. 2020. PMID: 31721193 Free PMC article.
Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination.
Deme D, Kovacs S, Telekes A. Deme D, et al. Pathol Oncol Res. 2022 Jan 31;28:1610004. doi: 10.3389/pore.2022.1610004. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35173556 Free PMC article.
Impact of breast cancer care pathways and related symptoms on the return-to-work process: results from a population-based French cohort study (CONSTANCES).
Rolland AL, Porro B, Kab S, Ribet C, Roquelaure Y, Bertin M. Rolland AL, et al. Breast Cancer Res. 2023 Mar 22;25(1):30. doi: 10.1186/s13058-023-01623-6. Breast Cancer Res. 2023. PMID: 36949546 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information